drugset / Trial / NCT05452304
AZD7798 Safety, Tolerability, and Pharmacokinetics After a Single Ascending and Repeat Dose Administrations to Healthy Subjects, and Patients With Crohn's Disease
RandomizedSequentialQuadruple-blindTreatment
Summary
This study will assess the safety, tolerability, immunogenicity, and pharmacokinetics (PK), and explore the pharmacodynamics (PD) following single ascending dose administration and repeat dose administration in healthy subjects and patients with Crohn's disease.
Timeline
- Start
- 2022-07-12
- Primary completion
- 2024-11-14
- Completion
- 2024-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD7798 | Unknown | — | — |